Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > T2 BioSystems Appoints Ken Toso Vice President, Product Development

Abstract:
T2 Biosystems, Inc., a company developing the first point-of-care medical diagnostic products that enable rapid molecular and immunodiagnostic testing on a single instrument, today announced it has appointed Ken Toso as Vice President, Product Development.

T2 BioSystems Appoints Ken Toso Vice President, Product Development

Cambridge, MA | Posted on January 6th, 2010

This appointment and creation of a new position reflects the Company's progress in developing its technology for commercial utility as it moves from an alpha instrument completed in 2009 to beta instrument development during 2010.

T2 Biosystems is developing the next generation of medical diagnostic products through its proprietary technology, which combines nanotechnology and the miniaturization of proven MR technology. T2 Biosystems' magnetic resonance-based diagnostics are poised to offer improved speed, accuracy and efficiency, as well as portability to a broader range of settings including doctor's offices, homes and hospitals.

Mr. Toso brings to T2 BioSystems more than 25 years of industry experience in medical device technologies, spanning product research, development and manufacturing. His innovative product experiences and launches have spanned multiple clinical areas within the fields of in vitro diagnostics and medical devices, including General Surgery, Gynecology, Urology, Cardiology, Oncology and Blood Glucose Monitoring.

"We are delighted to welcome Ken to our leadership team as his expertise will be invaluable as we advance our technology towards the marketplace," said John McDonough, CEO of T2 Biosystems. "Ken is joining T2 at a critical time of our growth and evolution to a commercial- stage company."

Most recently, Mr. Toso served as Sr. Vice President of Engineering at Grove Instruments and as Vice President of Research and Development for the Oncology division of Boston Scientific where he directed the launch of eight new products in one year's time. Prior to Boston Scientific, Mr. Toso served as VP of R&D for ACMI Circon and had directed the launch of 22 new products within his 3-year tenure. Mr. Toso also served as Vice President of Engineering at Xylum and started his career at US Surgical, where he served in a variety of technical and management roles, directing the launch of more than 35 new products. Mr. Toso earned his Bachelor's degree in Mechanical Engineering from SUNY at Stony Brook and M.B.A. from the University of Bridgeport and holds more than 20 US granted patents.

T2 Biosystems' technology has been validated in multiple published journal articles and has shown to accurately analyze viruses, bacteria, proteins, hormones, DNA, small molecules and other diagnostic targets. The Company is developing a pipeline of diagnostic products based on its technology, including devices for hospitals, diagnostic laboratories and medical offices, as well as individual patients.

####

About T2 Biosystems
T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology, combining nanotechnology and miniaturized magnetic resonance (MR) technology to provide rapid, accurate and portable diagnostics. T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute of Technology, Harvard University, Harvard Medical School and Massachusetts General Hospital, and has assembled a world-class team, board of directors and scientific advisory board that collectively have a proven track record of translating technologic innovations into breakthrough products, building significant corporate value. T2 Biosystems is located in Cambridge, Massachusetts.

For more information, please click here

Contacts:
Yates Public Relations
Adriana Jenkins
617-744-1713

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Novel approach to magnetic measurements atom-by-atom October 1st, 2014

Nanoparticles Accumulate Quickly in Wetland Sediment: Aquatic food chains might be harmed by molecules "piggybacking" on carbon nanoparticles October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

Nanomedicine

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Announcements

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Appointments/Promotions/New hires/Resignations/Deaths

NREL Announces New Center Directors to lead R&D, Analysis Efforts September 30th, 2014

Jeff Andreson to Join Nanometrics as Chief Financial Officer September 4th, 2014

New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014

Nanometrics CFO to Resign for New Job Opportunity August 8th, 2014

Nanobiotechnology

Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Penn Team Studies Nanocrystals by Passing Them Through Tiny Pores September 26th, 2014

New NIH/DOE Grant for Life Science Studies at NSLS-II: Funding will support operation of three powerful experimental stations designed to reveal detailed structures of proteins, viruses, and more September 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE